Mei Tang

1.0k total citations · 1 hit paper
53 papers, 725 citations indexed

About

Mei Tang is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Mei Tang has authored 53 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 10 papers in Oncology and 9 papers in Epidemiology. Recurrent topics in Mei Tang's work include Liver Disease Diagnosis and Treatment (5 papers), Organic Light-Emitting Diodes Research (4 papers) and Natural product bioactivities and synthesis (4 papers). Mei Tang is often cited by papers focused on Liver Disease Diagnosis and Treatment (5 papers), Organic Light-Emitting Diodes Research (4 papers) and Natural product bioactivities and synthesis (4 papers). Mei Tang collaborates with scholars based in China, Australia and United States. Mei Tang's co-authors include Zhu Yuan, Aiping Tong, Liangxue Zhou, Gang Guo, Chunlai Nie, Xinyu Zhao, Wenhao Guo, Haifeng Qiu, Meijia Yang and Kunhong Zhong and has published in prestigious journals such as The Science of The Total Environment, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Mei Tang

49 papers receiving 716 citations

Hit Papers

Bacteroides thetaiotaomicron ameliorates mouse hepatic st... 2024 2026 2025 2024 10 20 30 40 50
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Bacteroides thetaiotaomicron ameliorates mouse hepatic steatosis through regulating gut microbial composition, gut-liver folate and unsaturated fatty acids metabolism
    2024 56 citations Hu Li, Xuekai Wang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mei Tang China 16 335 183 133 87 80 53 725
Connie Kang New Zealand 16 337 1.0× 200 1.1× 115 0.9× 126 1.4× 31 0.4× 55 949
Steffen Frese Switzerland 17 544 1.6× 151 0.8× 204 1.5× 116 1.3× 108 1.4× 26 979
Xuhui Li China 13 374 1.1× 153 0.8× 58 0.4× 43 0.5× 181 2.3× 41 744
Ke He China 18 403 1.2× 134 0.7× 90 0.7× 116 1.3× 203 2.5× 64 903
Jia‐Yi Zhang China 15 259 0.8× 89 0.5× 80 0.6× 41 0.5× 117 1.5× 75 683
Bin Song China 18 454 1.4× 165 0.9× 103 0.8× 49 0.6× 215 2.7× 60 844
Xiaoyu Cao China 17 486 1.5× 113 0.6× 44 0.3× 113 1.3× 101 1.3× 53 897
Na Tang China 17 456 1.4× 510 2.8× 271 2.0× 98 1.1× 87 1.1× 52 1.0k
Xueting Liu China 15 269 0.8× 83 0.5× 219 1.6× 67 0.8× 115 1.4× 31 611

Countries citing papers authored by Mei Tang

Since Specialization
Citations

This map shows the geographic impact of Mei Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei Tang more than expected).

Fields of papers citing papers by Mei Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei Tang. The network helps show where Mei Tang may publish in the future.

Co-authorship network of co-authors of Mei Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Mei Tang. A scholar is included among the top collaborators of Mei Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei Tang. Mei Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lei, Lei, Hu Li, Xuekai Wang, et al.. (2025). Tubulointerstitial nephritis antigen-like 1 promotes the progression of liver fibrosis after HCV eradication with direct-acting antivirals. International Journal of Biological Sciences. 21(2). 802–822.
2.
Pang, Xu, Jianrui Li, Hu Li, et al.. (2024). Isoechinulin B, a natural product from Antarctic fungus, attenuates acute liver injury by inhibiting excessive cell adhesion. European Journal of Pharmacology. 984. 177065–177065.
3.
Jiang, Jing, Hu Li, Hu Li, et al.. (2024). Upregulation of Hepatic Glutathione S-Transferase Alpha 1 Ameliorates Metabolic Dysfunction-Associated Steatosis by Degrading Fatty Acid Binding Protein 1. International Journal of Molecular Sciences. 25(10). 5086–5086. 4 indexed citations
4.
Tang, Mei, Qi Fan, Shi‐Kang Shen, et al.. (2024). Metarhizium dianzhongense sp. nov. and New Record of M. bibionidarum (Clavicipitaceae, Hyocreales) Attacking Insects from China. Diversity. 16(4). 201–201. 1 indexed citations
5.
Zhao, Jianlei, Jun Yang, Ke Li, et al.. (2023). Abrogation of ATR function preferentially augments cisplatin-induced cytotoxicity in PTEN-deficient breast cancer cells. Chemico-Biological Interactions. 385. 110740–110740. 2 indexed citations
6.
7.
Zhu, Jingyang, Mei Tang, Hu Li, et al.. (2023). Design, synthesis and triglyceride-lowering activity of tricyclic matrine derivatives for the intervention of non-alcoholic fatty liver disease. Bioorganic Chemistry. 142. 106925–106925. 3 indexed citations
8.
Wang, Xuekai, Jianrui Li, Mei Tang, et al.. (2023). Establishment and application of a high-throughput screening model for cell adhesion inhibitors. Frontiers in Pharmacology. 14. 1140163–1140163. 3 indexed citations
9.
Zhang, Zhen, et al.. (2022). Azospirillum Endophyticum sp. nov., an Endophyte of Paris Polyphylla Smith var. Yunnanensis. Current Microbiology. 80(1). 34–34. 1 indexed citations
10.
Li, Yan, Xiandao Pan, Qianqian Du, et al.. (2020). The antitumor activity and mechanism of MCL3 in G422 glioblastoma. World Journal of Traditional Chinese Medicine. 6(3). 353–353. 8 indexed citations
11.
Liu, Xiaoyu, Qianqian Du, Caiping Tian, et al.. (2020). Discovery of CAPE derivatives as dual EGFR and CSK inhibitors with anticancer activity in a murine model of hepatocellular carcinoma. Bioorganic Chemistry. 107. 104536–104536. 12 indexed citations
12.
Huang, Lulu, Mei Tang, Qianqian Du, et al.. (2019). <p>The effects and mechanisms of a biosynthetic ginsenoside 3β,12β-Di-O-Glc-PPD on non-small cell lung cancer</p>. OncoTargets and Therapy. Volume 12. 7375–7385. 11 indexed citations
13.
Tang, Mei, Qiuli Liu, Leyuan Zhou, et al.. (2018). The poly (ADP-ribose) polymerase inhibitor rucaparib suppresses proliferation and serves as an effective radiosensitizer in cervical cancer. Investigational New Drugs. 37(1). 65–75. 9 indexed citations
14.
Zhao, Jianlei, George Li, Litao Liu, et al.. (2018). Protective Effects of Rhubarb in Rats with Acute Pancreatitis and the Role of Its Active Compound Rhein on Mitochondria of Exocrine Cells. Evidence-based Complementary and Alternative Medicine. 2018(1). 7321352–7321352. 19 indexed citations
15.
Guo, Wenhao, Ke Li, Mei Tang, et al.. (2018). Combination of DESI2 and endostatin gene therapy significantly improves antitumor efficacy by accumulating DNA lesions, inducing apoptosis and inhibiting angiogenesis. Experimental Cell Research. 371(1). 50–62. 6 indexed citations
16.
Qiu, Haifeng, Jing Li, Qiuli Liu, Mei Tang, & Yuan Wang. (2018). Apatinib, a novel tyrosine kinase inhibitor, suppresses tumor growth in cervical cancer and synergizes with Paclitaxel. Cell Cycle. 17(10). 1235–1244. 39 indexed citations
17.
Lin, Chao, Jun Yang, Lei Li, et al.. (2017). Combination of DESI2 and IP10 gene therapy significantly improves therapeutic efficacy against murine carcinoma. Oncotarget. 8(34). 56281–56295. 5 indexed citations
18.
Yang, Jun, Xinyu Zhao, Mei Tang, et al.. (2017). The role of ROS and subsequent DNA-damage response in PUMA-induced apoptosis of ovarian cancer cells. Oncotarget. 8(14). 23492–23506. 61 indexed citations
19.
20.
Shao, Bin, Mei Tang, Ziqiang Li, et al.. (2012). Proteomics analysis of human umbilical vein endothelial cells treated with resveratrol. Amino Acids. 43(4). 1671–1678. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Connie Kang Breakdown of academic impact, for papers by Steffen Frese Breakdown of academic impact, for papers by Xuhui Li Breakdown of academic impact, for papers by Ke He Breakdown of academic impact, for papers by Jia‐Yi Zhang Breakdown of academic impact, for papers by Bin Song Breakdown of academic impact, for papers by Xiaoyu Cao Breakdown of academic impact, for papers by Na Tang Breakdown of academic impact, for papers by Xueting Liu
Rankless by CCL
2026